Baker Bros. Advisors (GP) LLC, Director at Kymera Therapeutics, Inc. (KYMR), bought 655,500 shares at $44.00 ($28.8M) on 2025-06-30, disclosed to the SEC on 2025-06-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.00 | 55,191 | $2.4M | 8.4% |
| 2 | $44.00 | 600,309 | $26.4M | 91.6% |
| Total | $44.00 avg | 655,500 | $28.8M | 100% |
| Filing → |
| KOD | BUY | 2026-09-30 | $63.4M | — | Filing → |
| TRDA | BUY | 2025-11-12 | $2.6M | — | Filing → |
| CELC | BUY | 2025-09-10 | $19.1M | — | Filing → |